title: [Cancer therapy-induced cardiotoxicity].
abstract: The incidence of cancer is raising and the treatments are increasingly aggressive. Consequently, physicians are regularly facing side effects of cytotoxic therapies. Cancer- therapy-induced cardiotoxicity is a serious complication because it can be fatal and causes a temporary or permanent cessation of the treatment. In this article, we summarize the mechanisms, the monitoring and the multidisciplinary management of patients with cancer-therapy induced cardiotoxicity.
authors.affiliation: Service d'Oncologie Médicale, CHU de Liège, Belgique.
authors.forename: P
authors.initials: P
authors.lastname: Frères
authors.affiliation: Service d'Oncologie Médicale, CHU de Liège, Belgique.
authors.forename: A
authors.initials: A
authors.lastname: Poncin
authors.affiliation: Service de Cardiologie, CHU de Liège, Belgique.
authors.forename: M
authors.initials: M
authors.lastname: Moonen
authors.affiliation: Laboratoire de Génétique Humaine, GIGA, Université de Liège, Belgique.
authors.forename: Cl
authors.initials: C
authors.lastname: Josse
authors.affiliation: GIGA-Sciences cardiovasculaires, Université de Liège, Belgique.
authors.forename: C
authors.initials: C
authors.lastname: Oury
authors.affiliation: Service de Génétique Humaine, CHU de Liège, Chargé de cours, Université de Liège, Belgique.
authors.forename: V
authors.initials: V
authors.lastname: Bours
authors.affiliation: Service de Cardiologie, CHU de Liège, Belgique.
authors.forename: P
authors.initials: P
authors.lastname: Lancellotti
authors.affiliation: Service d'Oncologie Médicale, CHU de Liège, Belgique.
authors.forename: G
authors.initials: G
authors.lastname: Jerusalem
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000145:classification; D066126:Cardiotoxicity / Q000453:epidemiology* / Q000209:etiology; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000453:epidemiology*
chemical_list: D000970:Antineoplastic Agents
keywords:  Cancer ;  Cardiotoxicity ;  Chemotherapy ;  Therapies ;  Trastuzumab